Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp Ads (NQ: AMRN )

5.990 USD +0.270 (+4.72%)
Official Closing Price Updated: 7:59 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Amarin Corp Ads

< Previous 1 2 3 4 5 6 7 8 9
...
40 41 Next >
Amarin's Vascepa Sales Jump 34% in Q2 Despite COVID-19 Headwinds
The big wild card for the company now is its appeal of a court ruling invalidating key patents for the high triglyceride drug. 
Tags AMRN Market News
From Motley Fool
The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) ABIOMED, Inc. (NASDAQ: ABMD) ALX Oncology Holdings Inc ... 
Tags TRVN VAPO IMMU
From Benzinga
Recap: Amarin Q2 Earnings
Shares of Amarin Corp (NASDAQ:AMRN) rose 2.2% in pre-market trading after the company reported Q2 results. Quarterly ... 
Tags Market News AMRN Earnings
From Benzinga
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical ... 
Tags TRXC HZNP INCY
From Benzinga
AMRN September 11th Options Begin Trading
Investors in Amarin Corp plc (AMRN) saw new options begin trading today, for the September 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRN options... 
Tags Stocks
From Market News Video
Analysts Predict 13% Upside For IBB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Here's Why Amarin Tumbled 67.7% in the First Half of 2020
The pharma stock collapsed on the threat of generic competition for a drug that launched in December 2019, but the move may have been a bit of an overreaction. 
Tags Market News AMRN RDY
From Motley Fool
Wall Street Has Given Up on These 2 Stocks, and That's a Huge Mistake
Why StoneCo and bluebird bio are wonderful buys right now. 
Tags BRK/B Market News NVAX
From Motley Fool
Amarin Settlement With Apotex An 'Incremental Positive,' Says Stifel
Stifel analyst Derek Archila reiterates his Hold rating on Amarin shares after the company settled with Apotex regarding its ANDA application for generic Vascepa. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Amarin Analysts Say Vascepa Patent Settlement Not A Stock Mover, With 'Little Readthrough For Pending Patent Appeal'
Amarin Corporation plc (NASDAQ: AMRN) announced late Tuesday a settlement agreement with Apotex for resolving a patent lawsuit regarding ... 
Tags Vascepa AMRN Derek Archila
From Benzinga
The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked
Here's a roundup of top developments in the biotech space over the last 24 hour. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ODT Biotech XBI
From Benzinga
40 Stocks Moving in Wednesday's Pre-Market Session
Gainers Energous Corporation (NASDAQ: WATT) shares rose 126.2% to $5.00 in pre-market trading after the company reported a ... 
Tags CARV FLGT KXIN
From Benzinga
Market Briefing For Wednesday, June 17
The repeated and projected rallies off the 200-Day Moving Average, would not have been blessed with success if not for favorable news on the COVID-19 front as well as a continually friendly Fed. 
Tags Currencies/Forex Technology Pharma/Biotech
From Blogs - TalkMarkets
10 Stocks Moving In Tuesday's After-Hours Session
Gainers Fulgent Genetics (NASDAQ: FLGT) shares are trading higher after the company announced it launched an at-home testing ... 
Tags GAN NCLH RCL
From Benzinga
PPH's Holdings Imply 21% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
What’s Next For The Biotech Bull Market? Are you a Trader or an Investor?
Despite the economic pains of the pandemic, investors are driven to life science companies in the news with potential solutions for COVID-19. The potential for a COVID-19 vaccine or a new viral... 
Tags Pharma/Biotech Mutual Funds ETFs
From Blogs - TalkMarkets
FDA Approves Generic Version of Amarin's Blockbuster Fish Oil Capsules
The arrival of a generic version of Vascepa will be bad news for the company. 
Tags RDY AMRN HKMPY
From Motley Fool
Generic Threat To Amarin's Vascepa Overrides Positive Sentiment On Coronavirus Announcement
Amarin Corporation plc (NASDAQ: AMRN) shares, which were higher in after-hours trading Thursday following the company's announcement ... 
Tags Price Target Market News Covid/19
From Benzinga
Hikma receives FDA approval for generic of Amarin's Vascepa
Hikma Pharmaceuticals announced overnight that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA has received approval from the Food and Drug Administration for its Icosapent Ethyl Capsules,... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
1 Biotech Stock to Avoid at All Costs
U.S. patents protecting the only revenue source for this biotech company were recently invalidated, and the dust won't settle anytime soon. 
Tags RDY Market News HIK
From Motley Fool
20 Healthcare Stocks Moving In Friday's Pre-Market Session
Gainers • Medigus, Inc. (NASDAQ:MDGS) stock moved upwards by 45.22% to $3.95 during Friday's pre-market session. • ... 
Tags Trading Ideas ENTX SNDL
From Benzinga
The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Benzinga Penny Stocks TTPH
From Benzinga
8 Stocks Moving In Thursday's After-Hours Session
Gainers Agilent Technologies (NYSE: A) shares are trading higher after the company reported better-than-expected Q2 EPS and sales ... 
Tags Movers CFRX After/Hours Center
From Benzinga
Is Amarin Stock a Buy?
Record revenues, international growth, and a potential legal strategy may provide upside. 
Tags Market News AMRN ACAD
From Motley Fool
IBB's Holdings Imply 17% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
If You Invested $10,000 in Amarin's IPO, This Is How Much Money You'd Have Now
Not all IPO returns are equal. 
Tags INTU AMRN Market News
From Motley Fool
Northland Starts Amarin At Outperform Amid 'Major Paradigm Shift'
Northland analyst Carl Byrnes initiated coverage of Amarin with an Outperform rating and $15 price target. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Amarin a 'Strong buy' ahead of federal circuit ruling, says Roth Capital
Roth Capital analyst Yasmeen Rahimi sees COVID-19 disruptions as only a "minor distraction" from Amarin's continued commercial rollout of Vascepa. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Market Briefing for Friday, April 1
Superb market performance - for April, following our down-up turnaround nailed in March, actually yielded the best month in 33 years. 
Tags Services Stocks / Equities Technology
From Blogs - TalkMarkets
Amarin Corporation plc (AMRN) Q1 2020 Earnings Call Transcript
AMRN earnings call for the period ending March 31, 2020. 
Tags AMRN Market News
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.